consistent many across for have The market environment current and Thank over and around industry quarter our the seen results the comments and good with granularity been for quarter XXXX. potential with on companies reporting. areas then you, begin I our of we the how company afternoon, further level second affects what key healthcare experiencing Tony. customers. of And some the and is high everyone. the will I this the focus have market remainder discuss provide environment will last
to While overall recession inflation, future such also are customers uncertainty challenges other remain. continuing supply to and improved threat range chains access and of respect and affect a the budgets, concerns as There with rising are has staffing current capital critical of shortages customer to economic that customers.
pronounced to customers improvements more carefully, such This ultimately increasingly productivity of be a doing decisions, demand it. The with shift for of our models and driving demand and monthly While upfront our procurement, in strong in continues are have a of ease purchasing still as operational spending. lieu positives subscription months, business costs. marked other They're financial lower as other of and models exciting and we model with operational and measurable is are technology and in perpetual many business a associated factors licenses. in accounting the range subscriptions, traditional for seeing beginning increase recent for so compelling
add technologies trials easier capabilities enables of that reduces subscription not it to assessment personal customers acquisition. cost ongoing It customer barrier adopt method, long- solution, these be have can means Risk, customers typically and well gain expensed offers a as Subscription offer to clinical or can easier license greater makes and new by for to easily also have is they is to customer technology us recurring include as improvements, which generally typically customers, value the billing, ability such upfront clearly one-time opportunities after algorithm the option the And proof-of-concept This the too this revenue to lower new sooner, outlays. it more which firsthand. with payments they customers process. to uncertain what only value term offers our also can is avoid accelerated lengthy it a rather to entry predictable a approval our sale. The this annual ProFound than capital costly which our risk without quickly AI functionalities extends as access monthly stream. and also budget are which First, far upgrades, for capital performance them for much experienced of customers as
shift As at in I option we previously expected report order QX. than we the expecting discussed, pleased rapidly anticipated a more the that subscription market earlier am grown model this to in this subscription we to faster has And growing the customer and interest testing than meet accepted rate. this were in year. deals began in demand, monthly
US this our of QX. began in in X/X model, the a under fact, number In in well new came business of quarter deals as as European which
While customer. revenue acquired more been license these anticipated, if can more significantly was And of software Overall, than long-term there's across and history had of new to to shift benefits long spectrum the QX. in their generate revenue of moving originally than perpetual term model our we lower companies customers they in short And of subscription customers businesses a shareholders benefit than QX compelling. the the a a the industries. making are
healthcare preparing of is shift rate the our us necessary. for others, these to large position recurring accelerating shift the the for planning better to a healthcare rapidly, and model, be and customers term, company time this of At years realm XX% it this months for reportedly compared our in it the longer a greater base the long create it models year. generating to customer per at installed we and adoption revenue fast iCAD, dynamics anticipating believe the and propel growing type Although, been of taken appears will occur sustained configuring accordingly, in as in success towards business ahead. continue over even for is as We offerings business have to
transition. clear, of benefits do perpetual typically While model overcome model smaller a but to time move recurring the subscription are a relatively a have is to monthly model subscription to revenue payments. previous that hurdle predictable larger they revenue This as a impact move make the business as to license long-term software one they from short-term this companies reported
the experienced becomes phenomenon of this and model reported XXXX. the revenue in of business. a of subscription the the the of While of begin by XX revenue immediately, reported the of all sale we At of benefits optics challenge year, as the model And first subscription proportion larger reported halfway point of the is our half there subscriptions. the was impacted a the introduction
half Density over Risk were these and remaining our ProFound Solutions. AI and were the of mix Just
the this the short While is much of revenue, these There's will recurring to in first in term, their long-term half than higher. and XXXX. XXXX generate contribute customers optics value the therefore revenue the more customers in lower acquired And now recognized reported of we of typically at we lags recognize shipment typically which also revenue Subscriptions the of recognize with on Unlike upon how six shipment. installation, perpetual eight by are weeks. license, a difference a sale where in we the to timing subscriptions. revenue
installed QX in majority the the subscriptions So our in quarter. as they of not fully recognized been yet late have
patient confident continued are these addressable and are we improve the laying helping Not customers right success our relationships, path. reap market, expanding access are that and the However, benefits on streams from continue and total revenue predictable we only ahead. expanding years the will groundwork we we for long-term care, to months in technologies, to the
market meet of XXXX important mentioned rest plan to more for on the currently by of technologies, our leverage experiencing expanding an continue beyond and business, inflection to aggressively I the customer ways in and opportunities, robust we flexible of point strength powerful these call, our to offering access portfolio are our we our solutions targeting needs. As throughout broader to solutions last
by turning $X.X including result impact iCAD’s including Now I OUS detection I $X.X the deals on when again, not including up a model subscription faster number Therapy overall, million, business OUS US the from $X.X quarter described total of from of the This markets. XXXX. to the side challenging million on IORT provide ramp by impacted granularity We compared was QX. were QX mentioned environment. the our million, and impacted slower somewhat revenue a was and of Steve managed generally subscription US revenues ramp XX% these than on decrease in and IORT expenses elements. business, earlier. and the will subscription less relative more the factors Detection side well the market QX expected the both significantly the revenue the was to a of cash burn the in of impact both deals. to Not primarily
strategy, Breast see detection critical of staffing market continue have with world introduced workload, a from one months, customers of complete offers high partners in based teams, burnout. challenges overcome of who increasing volume model. and and positive personalized breast is a we recent facing These including Regarding are risk multi-vendor the today, solutions and leading for hospitals to to quarter, for solution Arterys, some business, AI short operational of technologies sales partners and AI our portfolio some physician serving most including evaluation. class suite as demand performance our clinical We of shortages assessment performance pleased across offer In were triad along desire imaging solutions our to pressing new detection, the as models grew. full of cancer iCAD’s positioning cloud superior our flexibility, term variability our singular breast today performance a unparalleled density performing who
more products using a And we of of also customers interest marketplace trio the in is helps differentiated increased products This density We products, offering. with for and clinicians outset. penetration the own. unmatched the new suite full these new customers value each compelling us on suite the opting at and our offers risk While of patients. to into to its with a complete are among seeing proposition improve the believe product strategy an
in As these to the more patients. world benefits more clinicians of technologies facilities, use about practice, are employ the we and physicians clinical they real learning offer
case attendance featured in which earlier, only and as is ProFound also Our profound radiologists AI, presented brought daily. to have been AI technologies all are and series, using several clinicians record life demonstrate Powerlook three Assessment These to life impact by studies this profound changing find having who it insight our truly how on impact cancer latest not Density concept ProFound webinar the but experts compelling case it using patients. Risk had leading studies
Using Additionally, XXX,XXX their next in models. at that in for traditional individual higher supporting grow findings a world's had cancer the or breast from Medscape, total of the and evidence negative screening risk risk last and largest in article on XX% more X.X the short-term media study In had Technology a personalized This study original outlets, that of from subsequently such peer next suite at US new health up quarter. risk reviewed million. women the clinicians found so reaching developing breast news. than from news Fierce of The the of risk multi indicator Karolinska studied, audience risk as was help than XX regimens ethnic compelling model guidelines, more general offers took Breast screening. XX continues risk their times population. sites. screening critical were the that Biotech cancer this picked also accurate trade of four consumer body compelling covered dozens than Day, ProFound more and based research Translational who an almost than individualized a covers women AI AI risk note, of and trade content Medicine can cancer of media actionable Influential information media published patients is screen with developing year AI News ProFound ProFound before potential lifetime Health Imaging this times journal to AI risk supporting Researchers Institute our study Science with involving a
progress including available market made penetration other our enterprise and to the broader level of quarter, also address our initiatives optimization, ability We improving across customers. major salesforce last
pipeline fact, larger enterprise of time customers any in other at In is history. than today's
is one make yet performing Although, in the QX. is one revamp our these beginning impact. new are of to our team these team of positive members highest salesforce some of sales With not new complete, hires of new ranking reps a
our in our are to have and and territories in salesforce team of additional just our continuing hires remained with realized rebuild not the their hires new territories some We QX, impact QX. yet open fully we in began new members of some as
fully strides in market. made penetrate to recently our We efforts have also the more broader
base with our While mammography sell limit supply of are may gantry XD installations, new struggles to seeing chain continued installed into selling current we success into systems. large makers’ some opportunity the
broader differentiated moving System a For success QX, competitive is we market example, technology. iCAD’s City. really Health at who forward expect great sales enterprise This the opportunity Kansas in saw a We we technology as Luke's this St. won order see superior leverage and procurement of account, in value and flexible targeted our we in options. efforts, large continued
customers. is These generally opportunities. strategic with of longer-term to enterprise the plan opportunity aspect a represent our level larger they important customers partnership better as of needs Another key address represent installations very
for opportunities, grow world order total secure is the institution our pleased same QX and also of the of in I to renowned spoke particularly another We call. opportunities this continue to models QX percentage demand strong on were these types segment. a As large from in academic operational about
Now segment our the turning to was our QX. business, led in expected which therapy improved dermatology revenue sales, depressed from a as by
positive. QX Xoft dermatology demand quarter. of of business This dermatology segment our just and gain environment for they experienced revenues recall, to really the QX, And user remains during initial is financing. starting the restructuring one will End you and we As the completed the impacted high were are partner versus improved partners has their while in QX reimbursement technology by momentum.
up pending with an of which recurrence outstanding has rates. updated follow expanded results of completion in nearing year clinical data the skin now five terms publication are of data, We body on
Our second expect we more robust the XXXX. half in ramping are up of results and partners
clinical progress will the also and remain the into trial technology patients brain optimistic continue this this deadly on cancer. We European to new have expect the with our of technology studying in use about QX. sites cancer We add our trial multinational in impact to treating
Sarno, Next, both to roles models. including our and drive of he companies introduce would model increased a perpetual to from served his SaaS work who brings Steve public for to technology appointed and team forward selected Steve experience We companies model. together continue and I the CFO at previously as business, in Steve a in transforming based organizations, like scale to shareholder experience May, welcome software company our SaaS enhance tremendous the We base a as Interim Steve? expertise amount offering private CFO value. to team to was in we look specifically as continuing to and Steve our